Health committee  I'd like to offer a comment on your previous question, if I may, about the cost of developing drugs. YM Biosciences is one of the group of very small companies that are in the business of taking risks in developing products, which may not be appropriate for a large pharmaceutical company.

Health committee  Good afternoon. YM Biosciences is an early stage cancer product development company, which was founded in 1994. We are currently developing new therapeutic products that we have licensed from the Universities of Saskatchewan, Manitoba, and Dalhousie. Our most advanced product is nimotuzumab, a biologically derived and produced molecule that is being developed for several underserved cancer indications.